tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Coproporphyria, Hereditary D046349 1 associated lipids
Ichthyosiform Erythroderma, Congenital D016113 1 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Asselin I et al. Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. 1994 Transplant. Proc. pmid:7527970
Kinoshita I et al. Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. 1994 Transplant. Proc. pmid:7527978
Reggiani P et al. Conversion to rescue therapy with FK 506: data from eight liver transplant patients. 1994 Transplant. Proc. pmid:7527982
Lemmens HP et al. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. 1994 Transplant. Proc. pmid:7527983
Arakawa H et al. Molecular cloning and expression of a novel human gene that is highly homologous to human FK506-binding protein 12kDa (hFKBP-12) and characterization of two alternatively spliced transcripts. 1994 Biochem. Biophys. Res. Commun. pmid:7513996
Mueller AR et al. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. 1994 Transplant. Proc. pmid:7527984
Langrehr JM et al. Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts. 1994 Transpl. Int. pmid:7513999
Tanabe M et al. The influence of donor and recipient strains in isolated small bowel transplantation in rats. 1994 Transplant. Proc. pmid:7527986
Leach KL et al. A soluble binding assay for measuring 3H-FK506 binding to the hsp56 immunophilin. 1994 J Immunoassay pmid:7530727
Genestier L et al. Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. 1994 Cell. Immunol. pmid:7514101
Yamamoto S and Kato R Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. 1994 J. Dermatol. Sci. pmid:7528050
Rao US and Scarborough GA Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. 1994 Mol. Pharmacol. pmid:7514263
Lieberman DN and Mody I Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. 1994 Nature pmid:7514273
Burdmann EA et al. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs. 1994 Ren Fail pmid:7514309
Jindal RM et al. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. 1994 Transplantation pmid:7514317
Igarashi T et al. Central nervous system toxicity related to FK506 in patients with Behçet's disease. 1994 Ann. Rheum. Dis. pmid:7517134
Eng WK et al. The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. 1994 Gene pmid:7530227
Ellis D et al. Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. 1994 Pediatr. Nephrol. pmid:7517171
Petros AM and Fesik SW Nuclear magnetic resonance methods for studying protein-ligand complexes. 1994 Meth. Enzymol. pmid:7530321
Klintmalm GB FK 506: an update. 1994 Clin Transplant pmid:7517226
Dawson TM et al. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. 1994 Neuroscience pmid:7530348
Morikawa K et al. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. 1994 Antimicrob. Agents Chemother. pmid:7532933
Curley RW et al. Stereospecific assignments of glycine in proteins by stereospecific deuteration and 15N labeling. 1994 J. Biomol. NMR pmid:7517241
Nagase K et al. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. 1994 J. Pharm. Pharmacol. pmid:7517447
Glaum SR and Miller RJ Inhibition of phosphoprotein phosphatases blocks metabotropic glutamate receptor effects in the rat nucleus tractus solitarii. 1994 Mol. Pharmacol. pmid:7517497
Tanaka K et al. Living related liver transplantation in children. 1994 Am. J. Surg. pmid:7517649
Jain A et al. FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. 1994 Transplant. Proc. pmid:7518149
Takara T et al. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. 1994 Transplant. Proc. pmid:7518150
Singh N et al. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? 1994 Dig. Dis. Sci. pmid:7506641
Kusne S et al. Infectious complications after small bowel transplantation in adults. 1994 Transplant. Proc. pmid:7518153
Lee TK et al. Bacterial translocation and the role of postoperative selective bowel decontamination in small intestinal transplantation. 1994 Transplant. Proc. pmid:7518154
Grossi P et al. Infectious complications in experimental small bowel transplantation. 1994 Transplant. Proc. pmid:7518155
D'Ambrosio R et al. Improved procedures for enzyme immunoassay of tacrolimus (FK506) in whole blood. 1994 Clin. Chem. pmid:7507007
Bäckman L et al. Chronic nephrotoxicity of FK 506 after liver transplantation. 1994 Transplant. Proc. pmid:7518159
Bäckman L et al. Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity. 1994 Transplant. Proc. pmid:7518160
Dilling MB et al. Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. 1994 Cancer Res. pmid:7508822
Yamamoto S et al. Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. 1994 J. Invest. Dermatol. pmid:7508960
Funauchi M et al. Effects of an inhibitor for calcium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex. 1994 Neurosci. Res. pmid:7520143
Logan TM et al. Structural characterization of the FK506 binding protein unfolded in urea and guanidine hydrochloride. 1994 J. Mol. Biol. pmid:7508991
Ito T et al. Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein. 1994 J. Gastroenterol. pmid:7520321
Cooper MH et al. Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. 1994 Transplantation pmid:7509089
Zeniya A et al. Anti-ulcer effect of FK 506, immunosuppressive agent, in rats. 1994 J. Gastroenterol. pmid:7520322
Rosh JR et al. Therapy with FK 506 in pediatric liver recipients. 1994 Transplant. Proc. pmid:7509091
Yamamoto S et al. Inhibition of anthralin-caused skin tumor promotion and interleukin-1 alpha production by potent immunosuppressant FK506. 1994 Cancer Lett. pmid:7520353
Scantlebury VP et al. Pediatric kidney transplantation at the University of Pittsburgh. 1994 Transplant. Proc. pmid:7509095
Dawson TM et al. Nitric oxide: cellular regulation and neuronal injury. 1994 Prog. Brain Res. pmid:7533914
Enslen H and Soderling TR Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. 1994 J. Biol. Chem. pmid:7520433
Sewell TJ et al. Inhibition of calcineurin by a novel FK-506-binding protein. 1994 J. Biol. Chem. pmid:7520438
Oyanagui Y Nitric oxide- and hydrogen peroxide-mediated gene expression by glucocorticoids and FK506 in histamine paw edema of mice. 1994 Life Sci. pmid:7520521
Gonschior AK et al. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA). 1994 Br J Clin Pharmacol pmid:7534100
Tacrolimus (FK506) for organ transplants. 1994 Med Lett Drugs Ther pmid:7520968
Bierer BE Biology of cyclosporin A and FK506. 1994 Prog. Clin. Biol. Res. pmid:7536944
Malyszko J et al. FK 506 affects platelet aggregation in vitro. 1994 Thromb. Res. pmid:7521072
Schreier MH Immunophilins and immunosuppression by cyclosporins and macrolide structures. 1994 Acta Derm Venereol Suppl (Stockh) pmid:7521103
Chen Y et al. A putative sirolimus (rapamycin) effector protein. 1994 Biochem. Biophys. Res. Commun. pmid:7521160
Tsuchida M et al. Effects of irradiation, glucocorticoid and FK506 on cell-surface antigen expression by rat thymocytes: a three-colour flow cytofluorometric analysis. 1994 Immunology pmid:7530693
Meadows RP et al. A computer-based protocol for semiautomated assignments and 3D structure determination of proteins. 1994 J. Biomol. NMR pmid:7510556
Mouzaki A and Rungger D Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. 1994 Blood pmid:7522636
Abu-Elmagd K et al. Three years clinical experience with intestinal transplantation. 1994 J. Am. Coll. Surg. pmid:7522850
Shapiro R et al. Improving results of pediatric renal transplantation. 1994 J. Am. Coll. Surg. pmid:7522851
Moia LJ et al. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. 1994 Brain Res. pmid:7522929
Holländer GA et al. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function. 1994 Transfus Sci pmid:10155542
Pai SY et al. Cross-linking CD28 leads to activation of 70-kDa S6 kinase. 1994 Eur. J. Immunol. pmid:7523138
Schmidt B et al. A homodimer represents an active species of the peptidyl-prolyl cis/trans isomerase FKBP25mem from Legionella pneumophila. 1994 FEBS Lett. pmid:7523184
Kattner A et al. Conversion from CyA to CyA-NOF in a cholestatic liver grafted patient with CyA malabsorption. 1994 Transplant. Proc. pmid:7524225
Fung JJ and Starzl TE FK 506 in solid organ transplantation. 1994 Transplant. Proc. pmid:7524226
Tacrolimus introduced for use in liver transplantation. 1994 Am J Hosp Pharm pmid:7524317
Przepiorka D et al. Blood tacrolimus concentration unchanged by plasmapheresis. 1994 Am J Hosp Pharm pmid:7524318
Burnett D et al. Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis. 1994 Biochem. Pharmacol. pmid:7524504
Bierer BE Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. 1994 Chem. Immunol. pmid:7524531
Lepre CA et al. Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12. 1994 Biochemistry pmid:7524662
Shaw LM and Brayman KL FK-506 therapeutic drug monitoring. 1994 Clin. Chem. pmid:7527305
Ishii T et al. Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury. 1994 Transpl. Int. pmid:11271294
Winkler M et al. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. 1994 Clin. Chem. pmid:7527306
Platz KP et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. 1994 Transpl. Int. pmid:11271297
Lewis HM Therapeutic progress. II: Treatment of psoriasis. 1994 J Clin Pharm Ther pmid:7527403
Metcalfe S et al. FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. 1994 Transpl. Int. pmid:11271304
Chen SR et al. Asymmetrical blockade of the Ca2+ release channel (ryanodine receptor) by 12-kDa FK506 binding protein. 1994 Proc. Natl. Acad. Sci. U.S.A. pmid:7527548
Moutabarrik A et al. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. 1994 Transpl. Int. pmid:11271305
Mori A et al. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. 1994 Int. Arch. Allergy Immunol. pmid:7512393
Calmus Y [Rejection of a liver allograft. Diagnosis and treatment]. 1994 Ann Radiol (Paris) pmid:7527621
Winkler M et al. Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. 1994 Transpl. Int. pmid:11271312
Okubo Y et al. Cytokine production in patients with mite-sensitive bronchial asthma. 1994 Int. Arch. Allergy Immunol. pmid:7512395
Jiang H et al. The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival. 1994 Transpl. Int. pmid:7527637
Devlin J et al. FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group. 1994 Transpl. Int. pmid:11271328
Wilson JR et al. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. 1994 Muscle Nerve pmid:7512691
Lyons WE et al. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. 1994 Proc. Natl. Acad. Sci. U.S.A. pmid:7512727
Assan R et al. FK 506/fluconazole interaction enhances FK 506 nephrotoxicity. 1994 Jan-Feb Diabete Metab pmid:7520007
Perotti BY et al. FK 506 metabolism in male and female rat liver microsomes. 1994 Jan-Feb Drug Metab. Dispos. pmid:7512020
Akita K et al. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. 1994 Jan-Feb Cell Transplant pmid:7512875
Yasunami Y et al. Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance. 1994 Jan-Feb Cell Transplant pmid:7512876
Yoshida Y et al. Comparison of cardiac rejection in heart and heart-lung concordant xenotransplantation. 1994 Mar-Apr J. Heart Lung Transplant. pmid:7518252
Kay AB Immunosuppressive agents in chronic severe asthma. 1994 May-Jun Allergy Proc pmid:7523242
von Asmuth EJ et al. IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. 1994 May-Jun Eur. Cytokine Netw. pmid:7524716
Ryffel B et al. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. 1994 Nov-Dec Exp. Nephrol. pmid:7532090
Cacciarelli TV et al. Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. 1994 Oct-Dec ASAIO J. pmid:7532042
Karanam BV et al. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4. 1994 Sep-Oct Drug Metab. Dispos. pmid:7530623
McDiarmid SV et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. 1995 Transplantation pmid:7533345
Lee MJ et al. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. 1995 Pharm. Res. pmid:7494802
Arita S et al. Effect of FK 506 in experimental pancreas transplantation. 1995 Transplant. Proc. pmid:7536980